US. firms developed almost half of the important new drugs--those that are sold in all major markets around the ... such as health insurance companies, and the expansion of the market share of managed health care providers. Both of ... Furthermore, patents on many of the top-selling drugs will expire in the next few years, opening the door to even more competition among manufacturers of generic drugs.
|Title||:||How Health Care Reform Affects Pharmaceutical Research and Development|
|Author||:||Anna Cook, Philip Webre|